Floatz logo

VINCRISTINE SULFATE

AIDS-related Immunoblastic Large Cell Lymphoma

AIDS Malignancy ConsortiumSmall moleculePhase 2Dormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
47/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the AIDS-related Immunoblastic Large Cell Lymphoma cohort.

Asset / SponsorPhaseRating
PREDNISONE TABLETS
AIDS Malignancy Consortium
Phase 2B
Inno-206
AIDS Malignancy Consortium
Phase 2B
ETOPOSIDE
AIDS Malignancy Consortium
Phase 2B
Cyclophosphamide
AIDS Malignancy Consortium
Phase 2B
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
National Cancer Institute (NCI)
Phase 2B

View all 22 →

Same molecule, other indications

VINCRISTINE SULFATE is also rated in:

B-cell childhood acute lymphoblastic leukemiaDormant
A
Indicative ·
81 / 100
View asset →
diffuse large B-cell lymphomaDormant
A
Indicative ·
80 / 100
View asset →
Burkitt lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →